Zentiva S.A.'s latest marketcap:
As of 07/04/2025, Zentiva S.A.'s market capitalization has reached $732.18 M. According to our data, Zentiva S.A. is the 11478th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 732.18 M |
| Revenue (ttm) | 260.08 M |
| Net Income (ttm) | 53.82 M |
| Shares Out | 697.02 M |
| EPS (ttm) | 0.08 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/29/2025 |
Zentiva S.A.'s yearly market capitalization.
| Date | Market Cap(RON) | Change (%) | Global Rank |
|---|---|---|---|
| 11/20/2024 | 3.15 B | 54.79% | 11210 |
| 12/29/2023 | 2.04 B | 50.52% | 13709 |
| 12/30/2022 | 1.35 B | -20.49% | 15728 |
| 12/30/2021 | 1.7 B | -15.86% | 14876 |
| 12/28/2020 | 2.02 B | -9.38% | 11520 |
| 12/30/2019 | 2.23 B | 44.58% | 9828 |
| 12/28/2018 | 1.54 B | 7.56% | 10523 |
| 12/29/2017 | 1.43 B | 76.41% | 11958 |
| 12/30/2016 | 813.07 M | -4.41% | 13040 |
| 12/30/2015 | 850.6 M | 28.95% | 11964 |
Company Profile
About Zentiva S.A.
Zentiva S.A. is a pharmaceutical company specializing in the production and marketing of human-use medicines and preparations. Operating in Romania and internationally, the company focuses on delivering high-quality, affordable healthcare solutions.
Therapeutic Areas
Zentiva develops pharmaceutical products across a broad range of therapeutic areas, including:
- Cardiovascular diseases
- Anti-inflammatory and pain relief
- Urology
- Blood diseases
- Gastrointestinal and metabolic disorders
- Central nervous system
- Infections
- Respiratory systems
Generic Medicines
The company is a key player in the development of generic medicines, providing cost-effective alternatives to original pharmaceutical products without compromising quality. These solutions help make treatments accessible to a wider patient base.
Additional Offerings
Beyond pharmaceuticals, Zentiva supplies educational materials for both healthcare professionals and patients, supporting informed medical decisions and treatment adherence.
Company Background
Originally founded in 1962 as Sicomed S.A., the company rebranded to Zentiva S.A. in January 2006. Headquartered in Bucharest, Romania, Zentiva operates as a subsidiary of Zentiva Group a.s.
Frequently Asked Questions
-
What is Zentiva S.A.'s (BVB-SCD) current market cap?As of 07/04/2025, Zentiva S.A. (including the parent company, if applicable) has an estimated market capitalization of $732.18 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Zentiva S.A. (BVB-SCD) rank globally by market cap?Zentiva S.A. global market capitalization ranking is approximately 11478 as of 07/04/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.